An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Authors
Dafydd Owen,
Charlotte AllertonAnnaliesa Anderson,
Lisa Aschenbrenner,
Mike Avery,
Simon Berritt,
Britton Boras,
Rhonda Cardin,
Anthony Carlo,
Karen Coffman,
Alyssa Dantonio,
Li Di,
Heather Eng,
Rose Ferre,
K.S. Gajiwala,
Scott Gibson,
S.E. Greasley,
Brett Hurst,
Eugene Kadar,
Amit Kalgutkar,
Jack Lee,
Jisun Lee,
Wei Liu,
Stephen Mason,
Stephen Noell,
Jonathan Novak,
R. Obach,
Kevin Ogilvie,
Nandini Patel,
Martin Pettersson,
K. Devendra,
Matthew Reese,
M. Sammons,
Jean Sathish,
Ravi Singh,
Claire Steppan,
Albert Stewart,
Jamison Tuttle,
Lawrence Updyke,
Patrick Verhoest,
Liuqing Wei,
Qingyi Yang +40 authors
,
Yuao Zhu Tip Tip